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1. Introduction 
The flavoprotein DT diaphorase (NAD(P)H:oxi- 
doreductase, EC 1.6.99.2) is a highly dicoumarol- 
sensitive enzyme catalyzing the oxidation of NADH 
and NADPH by various quinones and redox dyes 
[l-3]. The physiological electron acceptor for DT 
diaphorase has not yet been established. However, it 
has been suggested that the enzyme serves as a qui- 
none reductase in connection with conjugation of 
hydroquinones during detoxification, as well as in 
biosynthetic processes uch as the vitamin K-depen- 
dent y-carboxylation of glutamyl residues in pro- 
thrombin synthesis (reviewed [3]). 
Treatment of rats with polycyclic aromatic hydro- 
carbons, potent inducers of the aryl hydrocarbon 
monooxygenase system [4,5], is known to increase 
hepatic DT diaphorase [6-l 11. The induction of DT 
diaphorase is due to an increase in the amount of the 
enzyme [ 121. The coinduction of DT diaphorase and 
aryl hydrocarbon monooxygenase [3,9] has drawn 
attention to a possible linkage between the genetic 
regulation of these activities. 
truns8tilbene oxide has been suggested to repre- 
sent a new class of inducers of drug-metabolizing 
enzymes in the rat [ 13-161. This compound pre- 
ferentially induces epoxide hydratase [ 13-161 and 
glutathione S-transferases [161, whereas cytochrome 
P450 linked monooxygenase reactions are only 
moderately affected [ 13-171. Because of the speci- 
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ficity of this inducer, the level of DT diaphorase in 
TSO-treated rats has been investigated in order to 
obtain information about a possible coupling of the 
regulatory gene(s) of DT diaphorase and the aryl 
hydrocarbon monooxygenase system. 
2. Experimental 
2.1. Chemicals 
TSO was purchased from EGA-chemie (Steinheim/ 
Albuch) and was a7% pure by NMR and IR. 
Agarose C was obtained from Pharmacia (Uppsala). 
2,6-Dichlorophenolindophenol, dicoumarol, mena- 
dione, MTT (3(4,5-dimethylthiazolyl-2)-2,5-dipheynl 
tetrazolium bromide) NADH, Triton X-100 were 
bought from Sigma Chemical Co (St Louis, MO). 
All other chemicals were of analytical grade. 
2.2. Animals and preparations 
Male Sprague-Dawley rats weighing 180-200 g 
were used in all experiments. The rats were kept on a 
standard laboratory diet and starved 16 h before 
sacrifice. Some of the animals were injected i.p. with 
various amounts of TSO dissolved in 1 ml sunflower 
oil, as indicated in the figure legends. The rats were 
decapitated 24 h after the last injection. The 
105 000 X g supernatant fraction was prepared from 
20% (w/v) liver homogenates as in [ 121. 
2.3. Assays 
DT diaphorase activity was measured as in [ 121 
employing NADH as electron donor and 2,6-dichloro- 
phenolindophenol as electron acceptor. The enzyme 
activity was completely inhibited by lo-’ M dicou- 
marol. Protein was determined according to [ 181 
with bovine serum albumin as standard. 
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2.4. Immunological methods 
Antiserum raised against cytosolic DT diaphorase 
from rats treated with MC was obtained as in [ 121. 
Rocket immuno-electrophoresis and fused rocket 
immuno-electrophoresis were performed in 1% (w/v) 
agarose C containing 1% (v/v) antiserum against DT 
diaphorase as in [ 121. The plates were stained for 
menadione-mediated NADH-MTT reductase activity 
[ 121. The activity staining was totally inhibited by 
preincubation of the plates with 10m3 M dicoumarol. 
3. Results and discussion 
In fig.1. is shown the time course of induction of 
cytosolic DT diaphorase after administration of TSO 
to rats. No significant increase in enzyme activity is 
observed within the first 24 h after injection of the 
inducer. This lag period is much longer than that 
observed for the induction of cytosolic DT diapho- 
rase by treatment of rats with MC [3,9,19]. As early 
as 12 h after a single injection of MC, a 3-fold 
enhancement of enzyme activity was found [3,9,19]. 
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Fig.1. Time course of the changes in cytosolic DT diaphorase 
brought about by treatment of rats with TSO. Rats were 
injected once daily for l-5 days, as indicated by the arrows, 
with 400 mg TSO/kg body weight and killed 24 h after the 
fii injection. DT diaphorase activity was measured as in 
section 2, in duplicates. Each time-point represents the. 
average (t SD) of the individual values obtained with a group 
of 3 rats. (e-e) Rats injected with TSO; (o-o) rats 
injected with sunflower oil. 
Whether this time discrepancy in enzyme induction 
is the result of differences in the rate of distribution 
of these inducers or due to a different induction 
mechanism remains to be determined. 
Maximal DT diaphorase activity, 4-5-fold higher 
than the control value, was obtained after 4-5 days 
of TSO-treatment of rats (fig.1). After the final injec- 
tion with TSO the enzyme activity decreases lowly; 
the level of DT diaphorase in the cytosol is still 2.5- 
fold higher than that of controls 6 days after cessa- 
tion of the treatment. Both the time course of induc- 
tion of DT diaphorase by TSO and the slow return to 
control levels after the final injection of the inducer 
to rats are very similar to those observed for other 
enzymatic activities, such as epoxide hydratase [ 161 
and glutathione S-transferase(s) [161. 
In fig.2 the effect of different doses of TSO on 
cytosolic DT diaphorase is shown. The increase in 
enzyme activity did not entirely level off at higher 
doses of the inducer (400 mg/kg), an observation also 
made in the cases of epoxide hydratase [ 161 and 
glutathione S-transferase(s) [161. 
An enhanced enzyme activity in animals treated 
with an inducer does not a priori indicate an increase 
in the amount of enzyme. Recently, a sensitive 
method for determining concentrations of hepatic 
DT diaphorase was developed in this laboratory [ 121. 
The technique is based on rocket immuno-electro- 
260 360 
dose of TSO (mg I kg) 
Fig.2. Response of cytosolic DT diaphorase to different doses 
of TSO. Rats were injected once daily for 5 days with various 
doses of TSO and killed 24 h after the last injection. For 
further details see fig.1 and section 2. 
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phoresis with antibodies raised against purified 
cytosolic DT diaphorase. Analysis of cytosols from 
control and TSO-treated rats with this technique 
is shown in fig.3. The peak heights of known amounts 
Fig.3. Rocket immuno-electrophoresis of cytosolic DT 
diaphorase from control and TSO-treated rats. The rocket 
immuno-electrophoresis was performed as in section 2. The 
precipitates were detected with menadione-mediated tetra- 
zolium reductase activity as described. (A) Wells l-3 and 
9,10 contained known amounts of purified DT diaphorase: 
1, (33.5 ng); 2, (83.8 ng); 3, (167 ng); 9, (335 ng); 10, 
(670 ng). Wells 4,5 contained cytosol from control rats, 
105 and 210 pg protein, respectively, with spec. act. 0.9 
units/mg. Wells 6,7 contained cytosol from TSO-treated rats 
(400 mg TSO/kg, 5 days) 37 and 75 fig protein, respectively, 
with spec. act. 4.2 units/mg. Well 8 contained 140 pg cytosol 
protein from MC-treated rats (20 mg MC/kg, 3 days) with 
spec. act. 4.6 units/mg. (B) Peak heights in (A) from wells 
l-3 and 9,lO were employed as standard points in the deter- 
mination of the concentration of DT diaphorase in cytosols 
from control, TSO- and MC-treated rats. The amows indicate 
the peak heights from respective wells in (A). The concentra- 
tion of DT diaphorase was determined to 0.5, 2.6 and 2.8 
pg/mg cytosol protein in control, TSO- and MC-treated rats, 
respectively. 
of purified DT diaphorase (fig.3A) were determined 
and used as a standard curve (fig.3B). By determining 
the corresponding peak heights of cytosols from 
induced and non-induced animals the content of DT 
diaphorase was found to be 2.6 pg/mg cytosolic pro- 
tein and 0.5 I.cg/mg cytosolic protein, respectively. 
This 5.2-fold higher specific content of DT diapho- 
rase in TSO-treated rats correlates well with the 
4.7-fold higher specific activity observed in cytosols 
from induced rats. For comparison, the cytosol from 
MC-treated rats was also analyzed (fig.3). In agree- 
ment with [ 121 the extent of induction of DT 
diaphorase by MC was the same whether based on 
enzyme content or enzyme activity. Thus, as in the 
case of MC-treated animals, the enhanced DT diapho- 
rase observed in these TSO-treated rats is the result 
of an increase in enzyme concentration rather than 
altered enzyme properties. 
The nature of the assay for cytochrome P450, 
which measures the amount of heme contained in 
this protein, strongly suggests hat this cytochrome 
is also increased in amount by TSO treatment; while 
disc-gel electrophoretic patterns upport he same 
conclusion in the case of epoxide hydratase (J. S. 
and J. W. de P., unpublished). In addition, inhibitors 
of RNA and protein synthesis prevent he induction 
of epoxide hydratase by TSO [14]. Finally, quanti- 
tative immunoelectrophoresis has demonstrated that 
administration of TSO increases the amounts of gluta- 
thione S-transferases A-C in rat liver cytosol [20]. 
Cytosolic DT diaphorase has been shown to con- 
sist of several different antigenic forms, one of which 
is preferentially induced by MC-treatment of rats 
[ 121. The results from analysis of cytosols from 
TSO-induced animals with fused rocket immuno- 
electrophoresis indicate that the same antigenic form 
is induced by TSO (not shown). 
The relatively minor increase in microsomal cyto- 
chrome P450 content observed in TSO-treated rats 
is not accompanied by a 2 nm spectral shift in the 
peak absorption of the reduced CO-complex of the 
cytochrome [13-171, in contrast o that found in 
microsomes from MC-induced animals [4,5]. The rate 
of metabolism ofbenzo [a] pyreneand other polycyclic 
aromatic hydrocarbons i known to increase drasti- 
cally in MC-treated rats [4,5]. Some increase in the 
overall metabolism of benzo [alpyrene has also been 
observed in TSO-induced rats [ 15,171. The metabo- 
lite pattern of benzo [a] pyrene after monooxygena- 
tion in microsomes from TSO-treated rats [ 171 is 
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quite different from that obtained with microsomes 
from control and MC-treated rats [21,22 1. Additional 
studies on substrate specificity also support he con- 
clusion that the forms of cytochrome P450 induced 
by TSO and MC are not the same [23]. 
The induction of cytosolic DT diaphorase by TSO- 
treatment of rats was found to be of the same magni- 
tude as that observed in MC-treated animals of the 
same age [ 191. This response of DT diaphorase to 
TSO- and MC-treatment of rats indicates that the 
induction of DT diaphorase and that of cytochrome 
P448-catalyzed aryl hydrocarbon monooxygenase 
system are under separate genetic ontrol. Similar 
genetic differences have been reported in the mouse 
[24]. Their results uggest that there are two loci 
which regulate DT diaphorase induction by MC, 
one gene being the same as or closely linked to a 
gene regulation aryl hydrocarbon monooxygenase 
induction, the other unlinked and located on another 
chromosome. 
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